Targeting Metabotropic Glutamate Receptors for Novel Treatments of Schizophrenia

Molecular Brain - United Kingdom
doi 10.1186/s13041-017-0293-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptors in Schizophrenia Treatment

Trends in Neurosciences
Neuroscience
2015English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

Imaging of Metabotropic Glutamate Receptors (mGluRs)

2012English

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
2010English

Type 1 Metabotropic Glutamate Receptors (mGlu1) Trigger the Gating of GluD2 Delta Glutamate Receptors

EMBO Reports
BiochemistryGeneticsMolecular Biology
2013English

Role of Metabotropic Glutamate Receptors in Neurological Disorders

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

Metabotropic Glutamate Receptors (mGlus) and Cellular Transformation

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2008English

Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2018English

The Requirement of Presynaptic Metabotropic Glutamate Receptors for the Maintenance of Locomotion

Journal of Neuroscience
Neuroscience
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy